These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36618206)

  • 1. Prescribing pattern of anti-diabetic drugs and adherence to the American Diabetes Association's (ADA) 2021 treatment guidelines among patients of type 2 diabetes mellitus: A cross-sectional study.
    Tiwari K; Bisht M; Kant R; Handu SS
    J Family Med Prim Care; 2022 Oct; 11(10):6159-6164. PubMed ID: 36618206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing Pattern of Oral Antihyperglycaemic Drugs, Rationality and Adherence to American Diabetes Association (ADA) Treatment Guidelines among Type 2 Diabetes Mellitus (T2DM) Postmenopausal Women.
    Sharma S; Tandon VR; Roshi ; Mahajan A
    J Clin Diagn Res; 2016 Jan; 10(1):OC11-5. PubMed ID: 26894107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria.
    Yusuff KB; Obe O; Joseph BY
    Pharm World Sci; 2008 Dec; 30(6):876-83. PubMed ID: 18784982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing pattern and efficacy of anti-diabetic drugs in maintaining optimal glycemic levels in diabetic patients.
    Agarwal AA; Jadhav PR; Deshmukh YA
    J Basic Clin Pharm; 2014 Jun; 5(3):79-83. PubMed ID: 25278671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An observational multi-center study on type 2 diabetes treatment prescribing pattern and patient adherence to treatment.
    Butt MD; Ong SC; Rafiq A; Malik T; Sajjad A; Batool N; Chughtai AUH; Wahab MU; Abdullah M; Babar ZU
    Sci Rep; 2023 Dec; 13(1):23037. PubMed ID: 38155289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National trends in metformin-based combination therapy of oral hypoglycaemic agents for type 2 diabetes mellitus.
    Kim J; Park S; Kim H; Je NK
    Eur J Clin Pharmacol; 2019 Dec; 75(12):1723-1730. PubMed ID: 31475315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antidiabetic prescriptions, cost and adherence to treatment guidelines: A prospective, cross-sectional study at a tertiary care teaching hospital.
    Acharya KG; Shah KN; Solanki ND; Rana DA
    J Basic Clin Pharm; 2013 Sep; 4(4):82-7. PubMed ID: 24808678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study.
    Chan CW; Yu CL; Lin JC; Hsieh YC; Lin CC; Hung CY; Li CH; Liao YC; Lo CP; Huang JL; Lin CH; Wu TJ
    Cardiovasc Diabetol; 2018 Jan; 17(1):20. PubMed ID: 29368615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thailand diabetes registry project: glycemic control in Thai type 2 diabetes and its relation to hypoglycemic agent usage.
    Kosachunhanun N; Benjasuratwong Y; Mongkolsomlit S; Rawdaree P; Plengvidhya N; Leelawatana R; Bunnag P; Pratipanawatr T; Krittiyawong S; Suwanwalaikorn S; Deerochanawong C; Chetthakul T; Ngarmukos C; Komoltri C
    J Med Assoc Thai; 2006 Aug; 89 Suppl 1():S66-71. PubMed ID: 17715836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Review: Safety and Efficacy Comparison between Sulfonylureas and Dipeptidyl Peptidase-4 Inhibitors as Second-Line Therapies in Type 2 Diabetes Mellitus.
    Gillani SW; Moosvi AF
    Curr Pharm Des; 2020; 26(34):4315-4322. PubMed ID: 32268860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Six-month effectiveness and tolerability of pioglitazone in combination with sulfonylureas or metformin for the treatment of type 2 diabetes mellitus].
    Rodríguez A; Reviriego J; Polavieja P; Mesa J
    Med Clin (Barc); 2008 Nov; 131(19):721-30. PubMed ID: 19091199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cardiovascular risk factors with pioglitazone combination therapies in type 2 diabetes: an observational cohort study.
    Rodríguez A; Reviriego J; Karamanos V; del Cañizo FJ; Vlachogiannis N; Drossinos V;
    Cardiovasc Diabetol; 2011 Feb; 10():18. PubMed ID: 21314919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug utilization of oral hypoglycemic agents in a university teaching hospital in India.
    Sultana G; Kapur P; Aqil M; Alam MS; Pillai KK
    J Clin Pharm Ther; 2010 Jun; 35(3):267-77. PubMed ID: 20831529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of a Dipeptidyl Peptidase-4 Inhibitor/Thiazolidinedione Combination Drug for Patients With Type 2 Diabetes and Poor Glycemic Control: Difficulty With Patient Enrollment.
    Okamura K; Shirai K; Miyazaki M; Okuda T; Takamiya Y; Goto M; Urata H
    J Clin Med Res; 2019 Feb; 11(2):89-97. PubMed ID: 30701000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of Prescribing Sodium-Glucose Cotransporter-2 Inhibitors for Medicare Beneficiaries in the United States.
    Sangha V; Lipska K; Lin Z; Inzucchi SE; McGuire DK; Krumholz HM; Khera R
    Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e008381. PubMed ID: 34779654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Compliance of Physicians With the American Diabetes Association (ADA) Guidelines in Prescribing Cardioprotective Antihyperglycemic Agents to Diabetic Patients at a University Hospital in Jeddah, Saudi Arabia.
    Sheikh AM; Sheikh A; Alhozali A; Alshaikhi SA
    Cureus; 2023 Aug; 15(8):e44133. PubMed ID: 37753033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of pioglitazone on glycemic and lipid parameters and adverse events in elderly patients with type 2 diabetes mellitus: a post hoc analysis of four randomized trials.
    Rajagopalan R; Xu Y; Abbadessa M;
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):123-33. PubMed ID: 16860259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to oral antidiabetic agents with pioglitazone and metformin: comparison of fixed-dose combination therapy with monotherapy and loose-dose combination therapy.
    Barner JC
    Clin Ther; 2011 Sep; 33(9):1281-8. PubMed ID: 21840054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real-world comparison of mono and dual combination therapies of metformin, sulfonylurea, and dipeptidyl peptidase-4 inhibitors using a common data model: A retrospective observational study.
    Lee KA; Jin HY; Kim YJ; Kim SS; Cho EH; Park TS
    Medicine (Baltimore); 2022 Feb; 101(8):e28823. PubMed ID: 35212277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Utilization Study of Antidiabetic Drugs in Patients Attending Geriatric Outpatient Department at a Tertiary Care Hospital.
    Hannan A; Sinha SR; Ganiyani MA; Pustake M
    Cureus; 2021 Aug; 13(8):e17555. PubMed ID: 34646612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.